WEDNESDAY, Oct. 11, 2023 (HealthDay News) — New research points to the potential of a COVID-19 vaccine delivered through the nose. The phase 1 clinical trial showed that the product, administered nasally in two doses, delivered a significant immune response to multiple COVID variants. Called CoviLiv, the vaccine was testedContinue Reading
WEDNESDAY, Oct. 11, 2023 (HealthDay News) — Cigarette makers are using synthetic menthol substitutes in what appears to be an effort to skirt a looming federal menthol ban, researchers say. The menthol flavor appeals to younger and newer smokers, according to investigators at Duke Health in Durham, N.C., and YaleContinue Reading
TUESDAY, Oct. 10, 2023 (HealthDay News) — As many doctors and patients hail the advent of weight-loss drugs like Ozempic and Wegovy as the perfect fix for obesity, some experts are urging caution. The drugs are not well-tolerated by everyone struggling with obesity. For some folks, the weight piles backContinue Reading
MONDAY, Oct. 9, 2023 (HealthDay News) — Exercise has been dubbed “nature’s antidepressant” by doctors for years, and now a new study confirms the notion. The finding follows a four-month look at the impact that running had on anxiety and depression when compared to a common antidepressant. SSRIs (selective serotoninContinue Reading
SATURDAY, Oct. 7, 2023 (HealthDay News) — It’s time to get the flu shot. They’re important not just for adults, but also for children, and keeping the whole family safe, according to an expert in pediatrics. “You never know how bad a flu season will be,” said Dr. Mona Patel,Continue Reading
FRIDAY, Oct. 6, 2023 (HealthDay News) — Americans who haven’t been to college appear to be a risk group for drug overdose deaths. Deaths due to overdose increased among less-educated Americans, with the rate nearly doubling in a three-year period for those without a high school diploma, according to aContinue Reading
THURSDAY, Oct. 5, 2023 (HealthDay News) — Wallet-friendly cards showing proof of COVID vaccinations served a purpose early in the pandemic, but they’re on their way out. The U.S. Centers for Disease Control and Prevention has stopped printing the cards, likely changing how people track their shots in the future.Continue Reading
THURSDAY, Oct. 5, 2023 (HealthDay News) — While many have raved about the powers of popular weight-loss drugs like Wegovy and Ozempic, new research confirms the medications can trigger some nasty gastrointestinal side effects. Known as GLP-1 agonists, they may increase the risk of stomach paralysis, pancreatitis and bowel obstruction,Continue Reading
THURSDAY, Oct. 5, 2023 (HealthDay News) — U.S. cancer centers continue to have shortages of commonly used chemotherapy drugs, a new survey shows, though the medications are not as scarce as they were last June. The National Comprehensive Cancer Network (NCCN), a nonprofit alliance of leading cancer centers, surveyed itsContinue Reading
THURSDAY, Oct. 5, 2023 (HealthDay News) — Moderna Inc. announced Wednesday that it has seen positive early results with a new vaccine that would guard against four strains of flu plus COVID-19. In interim findings from a Phase 1/2 trial, the vaccine showed both a strong immune response compared toContinue Reading
THURSDAY, Oct. 5, 2023 (HealthDay News) — America’s kids are safer now than a decade ago when it comes to many types of injury, with two glaring exceptions: drugs and guns. That’s the crux of a new study that looked at injury trends among U.S. children and teenagers between 2011Continue Reading
THURSDAY, Oct. 5, 2023 (HealthDay News) — More than 80% of eligible Americans did not get a COVID-19 booster shot last fall. Now, a new study reveals the reasons for the hesitation. Nearly 40% of survey participants said a prior COVID-19 infection factored into their decision to not get theContinue Reading
WEDNESDAY, Oct. 4, 2023 (HealthDay News) — Federal regulators on Tuesday gave the go-ahead to an updated Novavax COVID vaccine, giving Americans a more traditional alternative to two recently revamped mRNA vaccines. Adolescents and adults who have previously received a COVID vaccine, but who haven’t gotten the newly updated PfizerContinue Reading
TUESDAY, Oct. 3, 2023 (HealthDay News) — Pharmaceutical companies that make the 10 prescription drugs chosen to be the first for price negotiations for Medicare patients have agreed to talks with the government. The Biden administration announced Tuesday that the drugmakers, including Merck, Bristol Myers Squibb and Johnson & Johnson,Continue Reading